Fact CheckerSign in

NCT05899023Recruiting

ED Diabetes Screening and Outpatient Care - Aim 3

Identifying Risk Factors for Poor Glycemic Control Among Emergency Department Patients and Improving Linkage to Outpatient Care

Source: ClinicalTrials.gov · Last updated 19 May 2026

Brief summary (registry, in English)

This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
2 Jun 2023
Start date
1 Dec 2025
Primary completion date
31 May 2028
Lead sponsor
NYU Langone Health
NCT number
NCT05899023

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 1 Dec 2025 to the primary completion date, 31 May 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • No prior history of diabetes

Lab values

  • No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)

Who the study is looking for

  • Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
  • Residential address in New York City or Long Island
  • Primary language is English or Spanish
  • Able to provide informed consent

Age in the registry: 20 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NYU Langone Health
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.